Candel Therapeutics, Inc. (CADL) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Candel Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • Candel Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$145 M, a 34.6% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$145 M -$37.4 M -34.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$137 M -$37.9 M -38.3% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 -$126 M -$31.9 M -34% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$117 M -$32.2 M -37.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$108 M -$26.7 M -32.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$99.1 M -$18.8 M -23.4% Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$94 M -$12.1 M -14.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$85.3 M -$19.6 M -29.8% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 -$81.2 M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$80.3 M -$36.1 M -81.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$81.9 M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$65.7 M Jun 30, 2021 10-Q 2021-09-08
Q4 2020 -$44.2 M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.